For All The Latest Thailand Medical News, COVID-19 News, Long COVID News, H5N1 News, Research News, Health News, Hospital News, Herb News, HIV News, Cancer News, Diabetes News, Alzheimer News, Anti-Aging News, Mental Health News, etc

COVID-19 News - SARS-CoV-2 N Proteins - Cell Apoptosis   May 11, 2023  4 months, 3 weeks, 1 day, 22 hours, 42 minutes ago

Study Finds That SARS-CoV-2 N Proteins Are Able To Suppress Cell Apoptosis To Facilitate Virus Replication. An Explanation For Asymptomatic Infections

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Study Finds That SARS-CoV-2 N Proteins Are Able To Suppress Cell Apoptosis To Facilitate Virus Replication. An Explanation For Asymptomatic Infections
COVID-19 News - SARS-CoV-2 N Proteins - Cell Apoptosis   May 11, 2023  4 months, 3 weeks, 1 day, 22 hours, 42 minutes ago
COVID-19 News: The ongoing COVID-19 pandemic has presented a complex puzzle for researchers and medical professionals alike. Among the most intriguing aspects of the SARS-CoV-2 virus is the vast range of clinical manifestations exhibited by infected individuals, from severe respiratory distress to completely asymptomatic cases. Understanding the mechanisms underlying asymptomatic infections, which can still transmit the virus, is crucial in developing effective prevention and treatment strategies.

Apoptosis - Pic Credit:Kateryna Kon / Shutterstock
A recent collaborative study led by researchers from Jinan University and Wuhan University in China has shed light on one of the key mechanisms behind asymptomatic SARS-CoV-2 infections.
The study findings reveal that the SARS-CoV-2 virus's Nucleocapsid (N) protein plays a critical role in suppressing cell apoptosis, a type of programmed cell death, to facilitate viral replication without causing respiratory dysfunction. This finding helps explain why asymptomatic individuals can have high viral loads but not display symptoms.
Apoptosis is a tightly regulated process that plays a crucial role in maintaining the ontogeny and homeostasis of organisms. It is an essential defense mechanism employed by the host to eliminate virus-infected cells, reduce viral replication, and avoid excessive immune and inflammatory responses. Viruses, however, have evolved strategies to inhibit apoptosis, ensuring their survival and replication within host cells.
SARS-CoV-2's N protein is a multifunctional protein essential for viral replication and assembly. Previous research has demonstrated that the N protein can activate the NLRP3 inflammasome, induce cytokine storms, cause lung injury, and interfere with various cellular processes. However, the molecular mechanisms by which the N protein regulates cell apoptosis and viral replication remained unclear.
The study team discovered that the N protein of SARS-CoV-2 specifically interacts with an anti-apoptotic protein called Myeloid cell leukemia-1 (MCL-1). MCL-1 is a member of the B-cell lymphoma 2 (BCL-2) family and is known to inhibit apoptosis by binding to pro-apoptotic proteins such as Bak and Bax. The study revealed that the N protein recruits a deubiquitinating enzyme called USP15 to remove K63-linked ubiquitination of MCL-1. This process stabilizes MCL-1 and promotes its interaction with Bak in the mitochondria, effectively suppressing apoptosis and facilitating viral replication.
Worryingly, the study also showed that the N protein enhanced the replications of other viruses, such as influenza A virus (IAV), Dengue virus (DENV), and Zika virus (ZIKV).
However, these effects could be blocked by a specific MCL-1 inhibitor, S63845, highlighting the critical role of MCL-1 in the N protein's anti-apoptotic function.
This research has important implications for understanding the high frequency of asymptomatic SARS-CoV-2 infections. By suppressing cell apoptosis, the N protein may help maintain the normal structure and function of the respiratory tract in infected individuals without causing symptoms. This mechanism allows the virus to replicate effectively without triggering a pathological response.
In addition to providing insight into the behavior of SARS-CoV-2 in asymptomatic individuals, the study also raises concerns about the risk of co-infections with other viruses. As the N protein promotes the replication of other viruses such as IAV, DENV, and ZIKV, individuals infected with SARS-CoV-2 may be more susceptible to co-infections.
 In fact, clinical analyses have revealed that co-infection of SARS-CoV-2 and influenza virus can lead to more severe clinical symptoms and higher mortality rates than separate infections. This has been covered in published studies and also in past COVID-19 News reports.
The discovery of the N protein's role in suppressing apoptosis and facilitating viral replication opens up new avenues for potential therapeutic interventions. Inhibiting the interaction between the N protein and MCL-1 or targeting the deubiquitination process could be effective strategies in reducing viral replication and alleviating disease symptoms. The MCL-1 inhibitor S63845, for instance, has shown promise in blocking the N protein's effects in the study and could be further explored as a potential therapeutic agent.
Another critical implication of this research is the importance of continued vigilance in identifying and managing asymptomatic SARS-CoV-2 infections. Given that asymptomatic individuals can have high viral loads and may unknowingly contribute to virus transmission, accurate testing and effective contact tracing remain crucial in controlling the spread of COVID-19. This becomes even more important considering the potential risk of co-infections and the increased severity of symptoms they can cause.
Furthermore, understanding the molecular mechanisms behind asymptomatic infections may inform vaccine development and optimization. Currently available vaccines have demonstrated efficacy in preventing severe COVID-19 cases, but breakthrough infections and asymptomatic cases still occur. Future vaccine strategies could potentially target the N protein-MCL-1 interaction or related pathways to reduce viral replication and minimize the risk of transmission, even in asymptomatic individuals.
While this study has provided valuable insights into the mechanisms behind asymptomatic SARS-CoV-2 infections, more research is needed to fully understand the complex interplay between the virus, host cells, and the immune system. As new variants of SARS-CoV-2 continue to emerge, it is crucial to monitor the impact of mutations on the N protein's function and evaluate the effectiveness of potential therapeutic interventions accordingly.
The study findings were published in the peer reviewed journal: Signal Transduction And Targeted Therapy. (Nature)
For the latest COVID-19 News, keep on logging to Thailand Medical News.


Sep 25, 2022  1 year ago
Source: Medical News - SARS-CoV-2 Fall And Winter 2022 Variant Collections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news